Biotech · Private company
GID BIO, Inc.
Track this companyFree. Adds GID BIO, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- GID SVF-2 Device SystemPhase 3 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- GID SVF-2Androgenetic AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- GID SVF-2Erectile DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- GID SVF-2Osteoarthritis (OA)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)NA · WITHDRAWN · started Oct 1, 2021ClinicalTrials.gov NCT03886402 · fetched Nov 12, 2026
- Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee OsteoarthritisPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 15, 2020ClinicalTrials.gov NCT04440189 · fetched Nov 12, 2026
- Adipose-derived SVF for Treatment of AlopeciaNA · COMPLETED · started Jul 20, 2016ClinicalTrials.gov NCT02626780 · fetched Nov 12, 2026
- Adipose-derived SVF for the Treatment of Knee OANA · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02726945 · fetched Nov 12, 2026